In vitro experiments found that the expression of microRNA-214 in chondrocytes and serum of LCPD patients was reduced, while overexpression of microRNA-214 promoted chondrocyte viability and reduced apoptosis by downregulating the apoptotic factor Bax. This evidence concerns the gene BAX and Legg-Calve-Perthes disease.